You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
本地口罩生產資助計劃再批出五條生產線
阿思達克 04-17 13:09
商務及經濟發展局公布,在本地口罩生產資助計劃下批出五宗申請,當中國藥科技醫療用品獲批一條生產線,預計於4月10日開始向政府供應獲認證口罩,每月平均向政府供應200萬個口罩,另每月平均生產100萬個口罩供應本地市場,該生產線可獲最高資助為300萬元。

Hong Kong Lion Production Company Limited獲批資助一條生產線。其申請中的預計目標日期為4月15日,每月平均向政府供應55萬個口罩,該生產線可獲得的最高資助為200萬元。

香港人醫療用品獲批資助一條生產線。其申請中的預計目標日期為4月16日,每月平均向政府供應200萬個口罩,另可每月平均生產160萬個口罩供應本地市場,該生產線可獲得的最高資助為300萬元。

益成醫療用品獲批資助一條生產線,其申請中的預計目標日期為4月16日,每月平均向政府供應200萬個口罩,另可每月平均生產100萬個口罩供應本地市場。該生產線可獲得的最高資助為300萬元。

新德利(亞洲)獲批資助一條生產線,其申請中的預計目標日期為4月16日,每月平均向政府供應120萬個口罩。該生產線可獲得的最高資助為200萬元。

計劃最多會資助20條本地生產線,至今已批出13條生產線,尚餘7條生產線資助名額。香港生產力促進局確認尚有26宗申請符合計劃基本條件,涉及33條生產線,政府會盡快審批。(el/u)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account